Skip to main content

  • Clinical Outcomes One Year and Beyond After Combination Sirolimus-Eluting Endothelial Progenitor Cell Capture Stenting During Primary Percutaneous Coronary Intervention in STEMI

    • Posted: 10/03/2019
    • Author:

      Hui Wen Sim, Elizabeth H. Thong, Huay Cheem Tan, Adrian F. Low, Chi-Hang Lee, Mark Y. Chan, Edgar L. Tay, Poay Huan Loh, Koo Hui Chan and Joshua P. Loh

    • CRM2019

    Highlights

    • The combination sirolimus eluting endothelial progenitor cell (EPC) capture stents may be beneficial in the setting of ST segment elevation myocardial infarction (STEMI).
    • 260 consecutive STEMI patients (283 lesions) were implanted with 313 combination sirolimus eluting EPC capture stents.
    • At a median follow up period of 23.4 months, target lesion failure was 8.8% and definite stent thrombosis was 1.9%.

    Abstract

    Background/purpose

    Primary percutaneous coronary intervention (PCI) during acute ST-segment elevation myocardial infarction (STEMI) represents a thrombotic milieu and is associated with delayed healing after stenting. The pro-healing combination sirolimus eluting endothelial progenitor cell (EPC) capture stents encourage early endothelialization after stenting and may be beneficial in the STEMI population. We aim to evaluate the clinical outcomes one year and beyond for patients with STEMI who received the combination sirolimus eluting EPC capture stents during primary PCI.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details